Currency in GBp
Earnings estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 3 | 1 | 14 | 14 |
Avg. Estimate | 0.29 | 0.41 | 1.55 | 1.68 |
Low estimate | 0.25 | 0.41 | 1.28 | 1.42 |
High estimate | 0.33 | 0.41 | 1.68 | 1.85 |
Year ago EPS | 0.34 | 0.44 | 1.52 | 1.55 |
Revenue estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 3 | 2 | 13 | 13 |
Avg. Estimate | 8.9B | 7.47B | 33.9B | 34.2B |
Low estimate | 8.32B | 7.18B | 32.34B | 33.2B |
High estimate | 9.87B | 7.76B | 37.03B | 34.96B |
Year ago sales | 10.94B | 11.24B | 39.19B | 33.9B |
Sales growth (year/est) | -18.70% | -33.50% | -13.50% | 0.90% |
Earnings history | 31/12/2021 | 31/03/2022 | 30/06/2022 | 30/09/2022 |
---|
Est. EPS | 0.33 | 0.41 | 0.34 | 0.46 |
Actual EPS | 0.34 | 0.44 | 0.4 | 0.55 |
Difference | 0.01 | 0.03 | 0.06 | 0.09 |
Surprise % | 3.00% | 7.30% | 17.60% | 19.60% |
EPS trend | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
Current estimate | 0.29 | 0.41 | 1.55 | 1.68 |
7 days ago | 0.29 | 0.4 | 1.48 | 1.61 |
30 days ago | 0.29 | 0.38 | 1.42 | 1.55 |
60 days ago | 0.3 | 0.33 | 1.45 | 1.58 |
90 days ago | 0.33 | 0.35 | 1.5 | 1.64 |
EPS revisions | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
Up last 7 days | N/A | N/A | 6 | 6 |
Up last 30 days | N/A | N/A | 9 | 8 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | 1 |
Growth estimates | GSK.L | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -14.70% | N/A | N/A | N/A |
Next qtr. | -6.80% | N/A | N/A | N/A |
Current year | 2.00% | N/A | N/A | N/A |
Next year | 8.40% | N/A | N/A | N/A |
Next 5 years (per annum) | 0.11% | N/A | N/A | N/A |
Past 5 years (per annum) | 0.63% | N/A | N/A | N/A |